Patents by Inventor Girish Aggunda Renukappa

Girish Aggunda Renukappa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS
    Publication number: 20230322724
    Abstract: The present invention provides heterocyclic compounds of formula (I), which are therapeutically useful as CBP/EP300 inhibitors. These compounds are useful in the treatment and/or prevention of diseases or disorders mediated by CBP and/or EP300 in an individual. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer, an N-oxide or an ester thereof.
    Type: Application
    Filed: September 9, 2021
    Publication date: October 12, 2023
    Inventors: Chandrasekhar ABBINENI, Susanta SAMAJDAR, Ramesh S. SENAIAR, Girish AGGUNDA RENUKAPPA, Subhendu MUKHERJEE, Suraj TATYASAHEB GORE, Gerd WOHLFAHRT, Mikko MYLLYMAKI
  • 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors
    Patent number: 9353107
    Abstract: The present application relates to novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives of formula (I), as protein kinase inhibitors. The invention particularly relates to compounds of formula (I), preparation of compounds and pharmaceutical compositions thereof. The invention further relates to pharmaceutically acceptable salts and compositions comprising the said novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives and their use in the treatment of various disorders.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: May 31, 2016
    Assignees: Aurigene Discovery Technologies Limited, Um Pharmauji Sdn. Bhd.
    Inventors: Venkateshwar Rao Gummadi, Subramanya Hosahalli, Srinivas Nanduri, Girish Aggunda Renukappa
  • 3-(Pyrazolyl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors
    Publication number: 20150336949
    Abstract: The present application relates to novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives of formula (I), as protein kinase inhibitors. The invention particularly relates to compounds of formula (I), preparation of compounds and pharmaceutical compositions thereof. The invention further relates to pharmaceutically acceptable salts and compositions comprising the said novel 3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives and their use in the treatment of various disorders.
    Type: Application
    Filed: July 1, 2013
    Publication date: November 26, 2015
    Applicants: Um Pharmauji Sdn. Bhd., Aurigene Discovery Industrial Area
    Inventors: Venkateshwar Rao Gummadi, Subramanya Hosahalli, Srinivas Nanduri, Girish Aggunda Renukappa
  • 5-(1H-Pyrazol-4-yl)-1H-Pyrrolo[2,3-b]Pyridine Derivatives as Kinase Inhibitors
    Publication number: 20150183781
    Abstract: The present application relates to novel 5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine derivatives of formula (I), as protein kinase inhibitors. The invention particularly relates to compounds of formula (I), preparation of compounds and pharmaceutical compositions thereof. The invention further relates to prodrugs, derivatives, polymorphs, pharmaceutically acceptable salts and compositions comprising the said novel 5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine compounds and their derivatives and their use in the treatment of various disorders.
    Type: Application
    Filed: July 25, 2013
    Publication date: July 2, 2015
    Applicants: Um Pharmauji Sdn. Bhd., Aurigene Discovery Technologies Limited
    Inventors: Venkateshwar Rao Gummadi, Subramanya Hosahalli, Srinivas Nanduri, Girish Aggunda Renukappa